Comparable Outcomes in Nonsecretory and Secretory Multiple Myeloma after Autologous Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 10, 2008, Pages 1134-1140

  Kumar, Shaji ^a   Pérez, Waleska S ^b   Zhang, Mei Jie ^b   Ballen, Karen ^c   Bashey, Asad ^d   To, L Bik ^e   Bredeson, Christopher N ^b   Cairo, Mitchell S ^f   Elfenbein, Gerald J ^g   Freytes, César O ^h   Gale, Robert Peter ⁱ   Gibson, John ^j   Kyle, Robert A ^a   Lacy, Martha Q ^a   Lazarus, Hillard M ^k   McCarthy, Philip L ^l   Milone, Gustavo A ^m   Moreb, Jan S ⁿ   Pavlovsky, Santiago ^m   Reece, Donna E ^o   Vesole, David H ^p   Wiernik, Peter H ^q   Hari, Parameswaran ^b   more..

^a MAYO CLINIC   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Blood and Marrow Transplant Group of Georgia   (United States)

^e INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^f NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^g BOSTON UNIVERSITY   (United States)

^h UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

ⁱ CELGENE CORPORATION   (United States)

^j ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^k UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^l ROSWELL PARK CANCER INSTITUTE   (United States)

^m Fundacion para Combatir La Leucemia   (Argentina)

ⁿ UNIVERSITY OF FLORIDA   (United States)

^o PRINCESS MARGARET HOSPITAL   (Canada)

^p ST VINCENT S COMPREHENSIVE CANCER CENTER   (United States)

^q NEW YORK MEDICAL COLLEGE   (United States)

more..

Author keywords

Autologous hematopoietic stem cell transplantation; Nonsecretory myeloma

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; METHYLPREDNISOLONE; VINCRISTINE;

ADULT; AGE; ANEMIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER RELAPSE; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HYPOALBUMINEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; NONSECRETORY MULTIPLE MYELOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLASMACYTOMA; PLASMACYTOSIS; SECRETORY MULTIPLE MYELOMA;

ADULT; ANALYSIS OF VARIANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; MULTIPLE MYELOMA; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 51649085303     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.07.011     Document Type: Article

References (25)

1. Azar H.A., Zaino E.C., Pham T.D., and Yannopoulos K. "Nonsecretory" plasma cell myeloma: observations on seven cases with electron microscopic studies. Am J Clin Pathol 58 (1972) 618-629
2. Joyner M.V., Cassuto J.P., Dujardin P., et al. Non-excretory multiple myeloma. Br J Haematol 43 (1979) 559-566
3. Dreicer R., and Alexanian R. Nonsecretory multiple myeloma. Am J Hematol 13 (1982) 313-318
4. Cavo M., Galieni P., Gobbi M., et al. Nonsecretory multiple myeloma. Presenting findings, clinical course and prognosis. Acta Haematol 74 (1985) 27-30
5. Rubio-Felix D., Giralt M., Giraldo M.P., et al. Nonsecretory multiple myeloma. Cancer 59 (1987) 1847-1852
6. Bourantas K. Nonsecretory multiple myeloma. Eur J Haematol 56 (1996) 109-111
7. Blade J., and Kyle R.A. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia. Hematol Oncol Clin North Am 13 (1999) 1259
8. Turesson I., and Grubb A. Non-secretory or low-secretory myeloma with intracellular kappa chains. Report of six cases and review of the literature. Acta Med Scand 204 (1978) 445-451
9. Drayson M., Tang L.X., Drew R., Mead G.P., Carr-Smith H., and Bradwell A.R. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood 97 (2001) 2900-2902
10. Smith D.B., Harris M., Gowland E., Chang J., and Scarffe J.H. Non-secretory multiple myeloma: a report of 13 cases with a review of the literature. Hematol Oncol 4 (1986) 307-313
11. Attal M., Harousseau J.L., Stoppa A.M., et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 335 (1996) 91-97
12. Child J.A., Morgan G.J., Davies F.E., et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348 (2003) 1875-1883
13. Segeren C.M., Sonneveld P., van der Holt B., et al. Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study. Blood 101 (2003) 2144-2151
14. Fermand J.P., Katsahian S., Divine M., et al. High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe. J Clin Oncol 23 (2005) 9227-9233
15. Coriu D., Weaver K., Schell M., et al. A molecular basis for nonsecretory myeloma. Blood 104 (2004) 829-831
16. Dul J.L., and Argon Y. A single amino acid substitution in the variable region of the light chain specifically blocks immunoglobulin secretion. Proc Natl Acad Sci USA 87 (1990) 8135-8139
17. Wu G.E., Hozumi N., and Murialdo H. Secretion of a lambda 2 immunoglobulin chain is prevented by a single amino acid substitution in its variable region. Cell 33 (1983) 77-83
18. Stavem P., Froland S.S., Haugen H.F., and Lislerud A. Nonsecretory myelomatosis without intracellular immunoglobulin. Immunofluorescent and ultramicroscopic studies. Scand J Haematol 17 (1976) 89-95
19. Preud'Homme J.L., Hurez D., Danon F., Brouet J.C., and Seligmann M. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma. Clin Exp Immunol 25 (1976) 428-436
20. Katzmann J.A., Abraham R.S., Dispenzieri A., Lust J.A., and Kyle R.A. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Clin Chem 51 (2005) 878-881
21. Shaw G.R. Nonsecretory plasma cell myeloma-becoming even more rare with serum free light-chain assay: a brief review. Arch Pathol Lab Med 130 (2006) 1212-1215
22. Terpos E., Apperley J.F., Samson D., et al. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients. Bone Marrow Transplant 31 (2003) 163-170
23. Attal M., Harousseau J.L., Facon T., et al. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 349 (2003) 2495-2502
24. Sirohi B., Powles R., Kulkarni S., et al. Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria. Bone Marrow Transplant 28 (2001) 29-37
25. Kumar S., Fonseca R., Dispenzieri A., et al. High incidence of IgH translocations in monoclonal gammopathies with abnormal free light chain levels. ASH Annu Meet Abstr 108 (2006) 3514